{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:36:22Z","timestamp":1740137782819,"version":"3.37.3"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","issue":"09","funder":[{"name":"R01","award":["HL141335"],"award-info":[{"award-number":["HL141335"]}]},{"DOI":"10.13039\/100011918","name":"Hemophilia of Georgia","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100011918","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Emory University Integrated Cellular Imaging Microscopy Core"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1055\/s-0044-1788559","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T23:24:24Z","timestamp":1721172264000},"page":"893-896","source":"Crossref","is-referenced-by-count":0,"title":["Marginal Zone B Cells Represent a Conserved Initiating Player in the Immune Response to Factor VIII in Hemophilia A Mice"],"prefix":"10.1055","volume":"124","author":[{"given":"Maya","family":"Maarouf","sequence":"first","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-3696","authenticated-orcid":false,"given":"Seema R.","family":"Patel","sequence":"first","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wallace Hunter","family":"Baldwin","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia E.","family":"Zerra","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States"},{"name":"Department of Laboratory Medicine and Pathology, Center for Transfusion Medicine and Cellular Therapies, Emory University School of Medicine, Atlanta, Georgia, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney","family":"Cox","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest T.","family":"Parker","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[{"name":"Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon L.","family":"Meeks","sequence":"additional","affiliation":[{"name":"Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,7,16]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1182\/blood-2008-06-160432","article-title":"How we treat a hemophilia A patient with a factor VIII inhibitor","volume":"113","author":"C L Kempton","year":"2009","journal-title":"Blood"},{"issue":"05","key":"ref2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ajh.23957","article-title":"Impact of inhibitors on hemophilia A mortality in the United States","volume":"90","author":"C E Walsh","year":"2015","journal-title":"Am J Hematol"},{"issue":"12","key":"ref3","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1182\/blood-2011-09-379453","article-title":"F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis","volume":"119","author":"S C Gouw","year":"2012","journal-title":"Blood"},{"issue":"08","key":"ref4","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1182\/blood-2012-06-434803","article-title":"The polygenic nature of inhibitors in hemophilia A: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort","volume":"121","author":"J Astermark","year":"2013","journal-title":"Blood"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1055\/s-0038-1655944","article-title":"HLA class II profile: a weak determinant of factor VIII inhibitor development in severe haemophilia A","volume":"77","author":"C R Hay","year":"1997","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref6","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1055\/s-0038-1655945","article-title":"HLA genotype of patients with severe haemophilia A due to intron 22 inversion with and without inhibitors of factor VIII","volume":"77","author":"J Oldenburg","year":"1997","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/j.1538-7836.2009.03636.x","article-title":"Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A","volume":"7","author":"A Pavlova","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"21","key":"ref8","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMoa1516437","article-title":"A randomized trial of factor VIII and neutralizing antibodies in hemophilia A","volume":"374","author":"F Peyvandi","year":"2016","journal-title":"N Engl J Med"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1056\/NEJMoa1208024","article-title":"Factor VIII products and inhibitor development in severe hemophilia A","volume":"368","author":"S C Gouw","year":"2013","journal-title":"N Engl J Med"},{"issue":"09","key":"ref10","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1182\/blood.2020009210","article-title":"Nonhuman glycans can regulate anti-factor VIII antibody formation in mice","volume":"139","author":"C M Arthur","year":"2022","journal-title":"Blood"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ajh.2830420408","article-title":"Loss of high-responder inhibitors in patients with severe hemophilia A and human immunodeficiency virus type 1 infection: a report from the Multi-Center Hemophilia Cohort Study","volume":"42","author":"G L Bray","year":"1993","journal-title":"Am J Hematol"},{"issue":"20","key":"ref12","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/bloodadvances.2019000650","article-title":"Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice","volume":"3","author":"W Jing","year":"2019","journal-title":"Blood Adv"},{"issue":"09","key":"ref13","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1002\/1521-4141(200009)30:9<2548::AID-IMMU2548>3.0.CO;2-H","article-title":"Role of CD154 in the secondary immune response: the reduction of pre-existing splenic germinal centers and anti-factor VIII inhibitor titer","volume":"30","author":"J Qian","year":"2000","journal-title":"Eur J Immunol"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1055\/s-0037-1616733","article-title":"Blockade of CD40\/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance","volume":"86","author":"B M Reipert","year":"2001","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1046\/j.1537-2995.1989.29589284147.x","article-title":"Disappearance of inhibitor to factor VIII in HIV-infected hemophiliacs with progression to AIDS or severe ARC","volume":"29","author":"M V Ragni","year":"1989","journal-title":"Transfusion"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/j.1538-7836.2009.03571.x","article-title":"Splenic marginal zone antigen-presenting cells are critical for the primary allo-immune response to therapeutic factor VIII in hemophilia A","volume":"7","author":"A Navarrete","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"23","key":"ref17","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood-2017-05-782912","article-title":"Marginal zone B cells are critical to factor VIII inhibitor formation in mice with hemophilia A","volume":"130","author":"P E Zerra","year":"2017","journal-title":"Blood"},{"issue":"03","key":"ref18","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jth.13936","article-title":"Early cellular interactions and immune transcriptome profiles in human factor VIII-exposed hemophilia A mice","volume":"16","author":"J D Lai","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"08","key":"ref19","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/jth.14204","article-title":"In-depth comparison of N-glycosylation of human plasma-derived factor VIII and different recombinant products: from structure to clinical implications","volume":"16","author":"K Canis","year":"2018","journal-title":"J Thromb Haemost"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fimmu.2020.00138","article-title":"Recombinant factor VIII Fc inhibits B cell activation via engagement of the Fc\u03b3RIIB receptor","volume":"11","author":"M T Georgescu","year":"2020","journal-title":"Front Immunol"},{"issue":"08","key":"ref21","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1182\/blood.2020009376","article-title":"Marginal zone B cells mediate a CD4 T-cell-dependent extrafollicular antibody response following RBC transfusion in mice","volume":"138","author":"P E Zerra","year":"2021","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.3389\/fimmu.2018.02516","article-title":"Marginal zone B cells induce alloantibody formation following RBC transfusion","volume":"9","author":"S R Patel","year":"2018","journal-title":"Front Immunol"},{"issue":"08","key":"ref23","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1182\/bloodadvances.2022008411","article-title":"Marginal zone B cells are responsible for the production of alloantibodies following platelet transfusion in mice","volume":"7","author":"A Couvidou","year":"2023","journal-title":"Blood Adv"},{"issue":"08","key":"ref24","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1074\/jbc.M312451200","article-title":"Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion","volume":"279","author":"C B Doering","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1788559.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T10:46:12Z","timestamp":1730803572000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0044-1788559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":24,"journal-issue":{"issue":"09","published-online":{"date-parts":[[2024,8,27]]},"published-print":{"date-parts":[[2024,9]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0044-1788559","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"type":"print","value":"0340-6245"},{"type":"electronic","value":"2567-689X"}],"subject":[],"published":{"date-parts":[[2024,7,16]]}}}